09.02.2023 22:05:00

Research Solutions Reports Fiscal Second Quarter 2023 Results

Reports 10.7% Total Revenue and 31% Platform Revenue Growth, Increase in ARR to $8.8 Million

HENDERSON, Nev., Feb. 9, 2023 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, reported financial results for its fiscal second quarter ended December 31, 2022.

(PRNewsfoto/Research Solutions, Inc.)

Fiscal Second Quarter 2023 Summary

  • Total revenue of $8.7 million, a 10.7% increase from prior-year quarter representing the Company's second consecutive quarter of double-digit revenue growth
  • Platform revenue up 31% to $2.1 million. Annual Recurring Revenue ("ARR") up 28% to $8.8 million
  • Gross profit up 20% from prior-year quarter. Total gross margin improved 300 basis points to 39.0%
  • Loss of $0.01 per share, compared to a loss of $0.02 per share in the prior-year quarter
  • Positive Adjusted EBITDA of $201,000 compared to loss of $165,000 in the prior-year quarter
  • Positive cash flow from operations of $0.9 million for the quarter and $1.0 million fiscal year to date, compared to negative cash flow from operations of $0.3 million in the same fiscal year to date period in the prior-year

"Our second quarter results reflect the ongoing strength of our business, including the adoption of our Platform by new customers and the second consecutive quarter of revenue growth in our Transactions business," said Roy W. Olivier, President and CEO of Research Solutions. "The increase in ARR during the quarter reflects the onboarding of new customers, expanded use of the Platform by existing customers including upgrades, and our new Curedatis offering introduced during the quarter. We believe our products deliver a solid return on investment to our customers and we continue to maintain good retention and positive upsell momentum in the present economic environment. While onboarding new customers has proved more challenging in recent quarters, I remain confident in the long-term growth prospects of our Platforms offering and our ability to attract and retain new customers."

Fiscal Second Quarter 2023 Results

Total revenue was $8.7 million, a 10.7% increase from $7.9 million in the year-ago quarter as both platform and transaction revenue increased from the prior period.

Platform subscription revenue increased 31% to $2.1 million compared to $1.6 million in the year-ago quarter. The increase was primarily due to an increase in the total number of paid Platform deployments, including 34 net deployments added in the quarter, as well as upsells to existing customers. The quarter ended with annual recurring revenue of $8.8 million, up 28% year-over-year (see the company's definition of annual recurring revenue below).

Transaction revenue was $6.6 million, compared to $6.3 million the second quarter of fiscal 2022. After historically being flat to down due to customer savings generated by the Platform, the Company has now experienced two consecutive quarters of transaction revenue growth. This growth does not include any impacts of the previously announced Fiz transaction, which will begin to contribute to the business in the fiscal third quarter. Transaction customer count for the quarter was 1,223, compared to 1,179 customers in the prior-year quarter (see the company's definition of active customer accounts and transactions below).

Total gross margin improved 300 basis points from the prior-year quarter to 39.0%. The increase was primarily driven by a continued revenue mix shift to the higher-margin Platform business which now constitutes approximately 24% of the Company's revenue and generates a majority of its gross profit.

Total operating expenses were $3.7 million, compared to $3.3 million in the second quarter of 2022. The increase was primarily due to non-cash stock compensation expense associated with the valuation of the Company's Long Term Equity Bonus ("LTEBP") program. The LTEBP replaces the prior restricted stock program for executives and attempts to better align executive compensation with stockholder interests through the provision of restricted stock grants that only vest if certain stock price thresholds are attained which range between $3.00 and $6.00 per share. More information on the LTEBP can be found in our quarterly Form 10-Q filing.

Net loss in the second quarter was ($256,000), or ($0.01) per share, compared to net loss of ($482,000), or ($0.02) per share, in the prior-year quarter. Removing the impact of the additional expense associated with the LTEBP, the net loss for the Company in the quarter would be roughly break-even. Adjusted EBITDA was $201,000, compared to a loss of $165,000 in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

Conference Call

Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.

Date: Thursday, February 9, 2023
Time: 5:00 p.m. ET (2:00 p.m. PT)
Dial-in number: 1-631-891-4304
Conference ID: 10020971

The conference call will be broadcast live and available for replay until March 9, 2023 by dialing 1-412-317-6671 and using the replay ID 10020971, and via the investor relations section of the company's website at https://researchsolutions.investorroom.com/.

Fiscal Second Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter
















Quarter Ended December 31,


Six Months Ended December 31,




2022

2021

Change

% Change


2022

2021

Change

% Change


Revenue:












Platforms

$   2,110,272

$   1,604,829

$      505,443

31.5 %


$     4,130,239

$     3,114,703

$    1,015,536

32.6 %



Transactions

$   6,606,394

$   6,267,458

338,936

5.4 %


$   13,271,070

$   12,500,088

770,982

6.2 %


Total Revenue

8,716,666

7,872,287

844,379

10.7 %


17,401,309

15,614,791

1,786,518

11.4 %













Gross Profit:












Platforms

1,857,199

1,373,161

484,038

35.2 %


3,646,693

2,637,379

1,009,314

38.3 %



Transactions

1,546,628

1,464,499

82,129

5.6 %


3,106,382

2,860,656

245,726

8.6 %


Total Gross Profit

3,403,827

2,837,660

566,167

20.0 %


6,753,075

5,498,035

1,255,040

22.8 %













Gross profit as a % of revenue:












Platforms

88.0 %

85.6 %

2.4 %



88.3 %

84.7 %

3.6 %




Transactions

23.4 %

23.4 %

0.0 %



23.4 %

22.9 %

0.5 %



Total Gross Profit

39.0 %

36.0 %

3.0 %



38.8 %

35.2 %

3.6 %














Operating Expenses:












Sales and marketing

666,608

518,357

148,251

28.6 %


1,187,824

1,041,308

146,516

14.1 %



Technology and product development

922,132

868,236

53,896

6.2 %


1,797,422

1,689,696

107,726

6.4 %



General and administrative

1,613,664

1,616,135

(2,471)

-0.2 %


3,133,088

3,113,358

19,730

0.6 %



Depreciation and amortization

6,342

4,260

2,082

48.9 %


12,154

7,156

4,998

69.8 %



Stock-based compensation

608,703

300,539

308,164

102.5 %


784,064

471,649

312,415

66.2 %



Foreign currency translation loss (gain)

(84,179)

11,982

(96,161)

NM


(11,663)

23,225

(34,888)

NM


Total Operating Expenses

3,733,270

3,319,509

413,761

12.5 %


6,902,889

6,346,392

556,497

8.8 %


Income (loss) from operations

(329,443)

(481,849)

152,406

31.6 %


(149,814)

(848,357)

698,544

82.3 %













Other Income (Expenses):












Other income (expense)

74,695

264

74,431

NM


113,764

540

113,224

NM



Provision for income taxes

(782)

-

(782)

NM


(4,915)

(5,770)

855

14.8 %



Gain on sale of disc'd operations

-

-

-



-

-

-



Total Other Income (Expenses):

73,913

264

73,649

NM


108,849

(5,230)

114,079

NM


Net income (loss)

$    (255,530)

$    (481,585)

226,055

46.9 %


$        (40,965)

$      (853,587)

812,623

95.2 %


Adjusted EBITDA

$      201,423

$    (165,068)

$      366,491

NM


$        634,741

$      (346,327)

$       981,069

NM
















Quarter Ended December 31,


Six Months Ended December 31,




2022

2021

Change

% Change


2022

2021

Change

% Change


Platforms:












ARR (Annual recurring revenue):












  Beginning of Period

$   8,331,770

$   6,282,927

$   2,048,843

32.6 %


$     7,922,188

$     5,880,179

$    2,042,009

34.7 %



   Incremental ARR

445,207

565,687

(120,480)

-21.3 %


854,789

968,434

(113,646)

-11.7 %



  End of Period

$   8,776,977

$   6,848,613

$   1,928,363

28.2 %


$     8,776,977

$     6,848,613

$    1,928,363

28.2 %














Deployments:












  Beginning of Period

756

590

166

28.1 %


733

553

180

32.5 %



   Incremental Deployments

34

56

(22)

-39.3 %


57

93

(36)

-38.7 %



  End of Period

790

646

144

22.3 %


790

646

144

22.3 %














ASP (Average sales price):












  Beginning of Period

$        11,021

$        10,649

$             372

3.5 %


$          10,808

$          10,633

$              175

1.6 %



  End of Period

$        11,110

$        10,602

$             509

4.8 %


$          11,110

$          10,602

$              509

4.8 %













Transaction Customers:












Corporate customers

921

867

54

6.2 %


922

860

62

7.2 %



Academic customers

302

312

(10)

-3.2 %


300

306

(6)

-2.0 %



Total customers

1,223

1,179

44

3.7 %


1,222

1,166

56

4.8 %













 

Active Customer Accounts, Transactions and Annual Recurring Revenue

The company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

The company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period.

Use of Non-GAAP Measure – Adjusted EBITDA

Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the company's operating results.

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other income (expense), foreign currency transaction loss, provision for income taxes, depreciation and amortization, stock-based compensation, gain on sale of discontinued operations, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):


Quarter Ended December 31,


Six Months Ended December 31,


2022

2021

Change

% Change


2022

2021

Change

% Change

Net Income (loss)

$    (255,530)

$    (481,585)

$      226,055

46.9 %


$        (40,965)

$      (853,587)

$       812,623

95.2 %

  Add (deduct)  








-


    Other income (expense)

(74,695)

(264)

(74,431)

NM


(113,764)

(540)

(113,224)

NM

    Foreign currency translation loss (gain)

(84,179)

11,982

(96,161)

-802.5 %


(11,663)

23,225

(34,888)

-150.2 %

    Provision for income taxes

782

-

782

NM


4,915

5,770

(855)

-14.8 %

    Depreciation and amortization

6,342

4,260

2,082

48.9 %


12,154

7,156

4,998

69.8 %

    Stock-based compensation

608,703

300,539

308,164

102.5 %


784,064

471,649

312,415

66.2 %

  Gain on sale of disc. ops.

-

-

-



-

-

-



$      201,423

$    (165,068)

$      366,491

NM


$        634,741

$      (346,327)

$       981,069

NM

 

About Research Solutions

Research Solutions, Inc. (NASDAQ: RSSS) provides cloud-based technologies to streamline the process of obtaining, managing, and creating intellectual property. Founded in 2006 as Reprints Desk, the company was a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on Article Galaxy, the company's SaaS research platform, to streamline access to the latest scientific research and data with 24/7 customer support. For more information and details, please visit www.researchsolutions.com and www.reprintsdesk.com

Important Cautions Regarding Forward-Looking Statements

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding additional customers, potential acquisitions and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission. 

 

Research Solutions, Inc. and Subsidiaries

Consolidated Balance Sheets












December 31, 







2022


June 30, 




(unaudited)


2022


Assets








Current assets:








Cash and cash equivalents


$

11,262,564


$

10,603,175


Accounts receivable, net of allowance of $71,019 and $94,144, respectively



5,243,386



5,251,545


Prepaid expenses and other current assets



343,629



276,026


Prepaid royalties



41,216



846,652


Total current assets



16,890,795



16,977,398










Other assets:








Property and equipment, net of accumulated depreciation of $855,494 and $840,996, respectively



55,165



47,985


Non-refundable deposit for asset acquisition



297,450




Deposits and other assets



924



893


Total assets


$

17,244,334


$

17,026,276










Liabilities and Stockholders' Equity








Current liabilities:








Accounts payable and accrued expenses


$

5,629,101


$

6,604,032


Deferred revenue



5,967,525



5,538,526


Total current liabilities



11,596,626



12,142,558










Commitments and contingencies
















Stockholders' equity:








Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding






Common stock; $0.001 par value; 100,000,000 shares authorized; 29,154,737 and 27,075,648 shares
issued and outstanding, respectively



29,155



27,076


Additional paid-in capital



28,874,383



28,072,855


Accumulated deficit



(23,135,237)



(23,094,272)


Accumulated other comprehensive loss



(120,593)



(121,941)


Total stockholders' equity



5,647,708



4,883,718


Total liabilities and stockholders' equity


$

17,244,334


$

17,026,276


 

Research Solutions, Inc. and Subsidiaries

Consolidated Statements of Operations and Other Comprehensive Loss

(Unaudited)


















Three Months Ended


Six Months Ended




December 31, 


December 31, 




2022


2021


2022


2021
















Revenue:














Platforms


$

2,110,272


$

1,604,829


$

4,130,239


$

3,114,703


Transactions



6,606,394



6,267,458



13,271,070



12,500,088


Total revenue



8,716,666



7,872,287



17,401,309



15,614,791
















Cost of revenue:














Platforms



253,073



231,668



483,546



477,324


Transactions



5,059,766



4,802,959



10,164,688



9,639,432


Total cost of revenue



5,312,839



5,034,627



10,648,234



10,116,756


Gross profit



3,403,827



2,837,660



6,753,075



5,498,035
















Operating expenses:














Selling, general and administrative



3,726,928



3,315,249



6,890,735



6,339,236


Depreciation and amortization



6,342



4,260



12,154



7,156


Total operating expenses



3,733,270



3,319,509



6,902,889



6,346,392
















Loss from operations



(329,443)



(481,849)



(149,814)



(848,357)
















Other income



74,695



264



113,764



540
















Loss from operations before provision for income taxes



(254,748)



(481,585)



(36,050)



(847,817)


Provision for income taxes



(782)





(4,915)



(5,770)
















Net loss



(255,530)



(481,585)



(40,965)



(853,587)
















Other comprehensive income (loss):














Foreign currency translation



6,524



185



1,348



(2,790)


Comprehensive loss


$

(249,006)


$

(481,400)


$

(39,617)


$

(856,377)
















Loss per common share:














Net loss per share, basic and diluted


$

(0.01)


$

(0.02)


$

-


$

(0.03)


Weighted average common shares outstanding, basic and diluted



26,816,550



26,351,947



26,767,360



26,314,532


 

Research Solutions, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(Unaudited)












Six Months Ended




December 31, 




2022


2021










Cash flow from operating activities:








Net loss


$

(40,965)


$

(853,587)


Adjustment to reconcile net loss to net cash provided by (used in) operating activities:








Depreciation and amortization



12,154



7,156


Fair value of vested stock options



301,737



127,668


Fair value of vested restricted common stock



482,327



343,981


Fair value of vested unrestricted common stock



68,272




Changes in operating assets and liabilities:








Accounts receivable



8,159



99,113


Prepaid expenses and other current assets



(67,603)



(55,609)


Prepaid royalties



805,436



249,775


Accounts payable and accrued expenses



(974,931)



(172,283)


Deferred revenue



428,999



(63,113)


Net cash provided by (used in) operating activities



1,023,585



(316,899)










Cash flow from investing activities:








Purchase of property and equipment



(18,876)



(26,991)


Payment for non-refundable deposit for asset acquisition



(297,450)




Net cash used in investing activities



(316,326)



(26,991)










Cash flow from financing activities:








Proceeds from the exercise of stock options





30,671


Proceeds from the exercise of warrants





59,500


Common stock repurchase



(48,729)



(67,812)


Net cash provided by (used in) financing activities



(48,729)



22,359










Effect of exchange rate changes



859



(3,092)


Net increase (decrease) in cash and cash equivalents



659,389



(324,623)


Cash and cash equivalents, beginning of period



10,603,175



11,004,337


Cash and cash equivalents, end of period


$

11,262,564


$

10,679,714










Supplemental disclosures of cash flow information:








Cash paid for income taxes


$

4,915


$

5,770


 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-fiscal-second-quarter-2023-results-301743548.html

SOURCE Research Solutions, Inc.

Analysen zu Research Solutions Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Research Solutions Inc 3,76 0,00% Research Solutions Inc